Skip to main content

Search This Blog

Biopharma Over Coffee

Updates on recent goings on in the pharma, biotech and healthcare sectors.

Posts

Showing posts from 2026

Anti-Amyloid Drugs in Alzheimer’s: Breakthrough, Dead End, or Reimbursement Reality Check?

Get link
Facebook
X
Pinterest
Email
Other Apps

February 12, 2026

MFN Pricing and the “Global Launch Freeze”: A More Measured Perspective

Get link
Facebook
X
Pinterest
Email
Other Apps

Newer Posts Older Posts Home

Powered by Blogger

Doug Niven: Each week, an article will cover something that you may have missed in the pharma, biotech or healthcare news, and perfect to read over a cup of coffee.

Followers

Archive

2026 2
- April 1
  - Anti-Amyloid Drugs in Alzheimer’s: Breakthrough, D...
- February 1
  - MFN Pricing and the “Global Launch Freeze”: A More...

2025 12
- December 1
- September 1
- August 1
- July 1
- May 2
- April 1
- March 1
- February 2
- January 2
2024 22
- November 1
- October 2
- September 1
- August 2
- July 3
- June 2
- May 4
- April 7

Show more Show less

Labels

3D Printing1
Access1
Acumen2
adagrasib2
Adaptimmune1
AIFA1
alpha synuclein2
ALS2
Alzheimer's Disease4
Amlyx1

Show more Show less

Report Abuse